Evidence map›Paper›PMID 34685528›Full record

ArticleCells2021

Intermittent High Glucose Elevates Nuclear Localization of EZH2 to Cause H3K27me3-Dependent Repression of KLF2 Leading to Endothelial Inflammation.

Sumukh Thakar, Yash T Katakia, Shyam Kumar Ramakrishnan, Niyati Pandya Thakkar, Syamantak Majumder

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Polycomb Repressive Complex 2 drives flow-sensitive endothelial states underlying vascular inflammation and disease.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Deletion of endothelial KLF4 as a model for preeclampsia.bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sumukh ThakarDepartment of Biological Sciences, Birla Institute of Technology and Science (BITS) Pilani, Pilani Campus, Pilani 333 031, Rajasthan, India.
Yash T KatakiaDepartment of Biological Sciences, Birla Institute of Technology and Science (BITS) Pilani, Pilani Campus, Pilani 333 031, Rajasthan, India.
Shyam Kumar RamakrishnanDepartment of Biological Sciences, Birla Institute of Technology and Science (BITS) Pilani, Pilani Campus, Pilani 333 031, Rajasthan, India.ORCID 0000-0002-8376-4772
Niyati Pandya ThakkarDepartment of Biological Sciences, Birla Institute of Technology and Science (BITS) Pilani, Pilani Campus, Pilani 333 031, Rajasthan, India.ORCID 0000-0003-1540-342X
Syamantak MajumderDepartment of Biological Sciences, Birla Institute of Technology and Science (BITS) Pilani, Pilani Campus, Pilani 333 031, Rajasthan, India.ORCID 0000-0001-8957-9810
Birla Institute of Technology and Science, Pilani · IN

Funding

Adhoc Research Project from the Indian Council of Medical Research, Govt. of India 55/1/2019-BMSDepartment of Biotechnology, Ministry of Science and Technology, India BT/PR33144/MED/30/2170/2019Science and Engineering Research Board ECR/2017/002153
6 · The paper itself

Abstract

Epigenetic mechanisms have emerged as one of the key pathways promoting diabetes-associated complications. Herein, we explored the role of enhancer of zeste homolog 2 (EZH2) and its product histone 3 lysine 27 trimethylation (H3K27me3) in high glucose-mediated endothelial inflammation. To examine this, we treated cultured primary endothelial cells (EC) with different treatment conditions-namely, constant or intermittent or transient high glucose. Intermittent high glucose maximally induced endothelial inflammation by upregulating transcript and/or protein-level expression of ICAM1 and P-selectin and downregulating eNOS, KLF2, and KLF4 protein levels. We next investigated the underlining epigenetic mechanisms responsible for intermittent hyperglycemia-dependent endothelial inflammation. Compared with other high glucose treatment groups, intermittent high glucose-exposed EC exhibited an increased level of H3K27me3 caused by reduction in EZH2 threonine 367 phosphorylation and nuclear retention of EZH2. Intermittent high glucose also promoted polycomb repressive complex-2 (PRC2) assembly and EZH2's recruitment to histone H3. Abrupt enrichment of H3K27me3 on

Indexed as

Cell NucleusEndothelial CellsEndotheliumEnhancer of Zeste Homolog 2 ProteinEpigenesis, GeneticHistonesHumansInflammationPolycomb Repressive Complex 2Protein Processing, Post-TranslationalEnhancer of Zeste Homolog 2 ProteinEZH2 protein, humanHistonesPolycomb Repressive Complex 2endothelial cellsenhancer of zeste homolog 2epigeneticsH3K27me3inflammationKLF2

Identifiers

PMID34685528
PMCPMC8534226
OpenAlexW3202474356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.